US Stock MarketDetailed Quotes
CKPT Checkpoint Therapeutics
- 3.370
- +0.070+2.12%
Close Nov 6 16:00 ET
151.71MMarket Cap-1970P/E (TTM)
3.485High3.280Low747.96KVolume3.390Open3.300Pre Close2.55MTurnover2.15%Turnover RatioLossP/E (Static)45.02MShares3.97052wk High-9.63P/B117.24MFloat Cap1.36052wk Low--Dividend TTM34.79MShs Float105.000Historical High--Div YieldTTM6.21%Amplitude1.300Historical Low3.405Avg Price1Lot Size
About Checkpoint Therapeutics Company
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.
Company Profile
SymbolCKPT
Company NameCheckpoint Therapeutics
Listing DateJun 26, 2017
Founded2014
CEOMr. James F. Oliviero, III
MarketNASDAQ
Employees23
Fiscal Year Ends12-31
Address95 Sawyer Road,Suite 110
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-781-652-4500
Websitehttp://www.checkpointtx.com
Company Executives
- Name
- Position
- Salary
- James F. Oliviero, III
- Director, President and Chief Executive Officer
- 1.64M
- Garrett Gray
- Chief Financial Officer, Corporate Secretary and Treasurer
- 712.88K
- Michael S. Weiss
- Chairman of the Board
- 110.00K
- Dr. Lindsay A. Rosenwald, M.D.
- Director
- 100.00K
- Barry Salzman
- Independent Director
- 100.00K
- Dr. Amit Sharma, F.A.C.P.
- Independent Director
- --
- Christian Bechon
- Independent Director
- 100.00K
- Neil Herskowitz
- Independent Director
- 110.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data